Related references
Note: Only part of the references are listed.Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous
Xiaoming Xing et al.
ADVANCES IN ANATOMIC PATHOLOGY (2015)
Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma
Rebecca L. Boddicker et al.
BIOMARKERS IN MEDICINE (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature
P. L. Zinzani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
Phillip B. Murray et al.
SCIENCE SIGNALING (2015)
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
Jikui Guan et al.
ELIFE (2015)
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
Phillip B. Murray et al.
SCIENCE SIGNALING (2015)
Survival in patients with limited-stage peripheral T-cell lymphomas
Robert Briski et al.
LEUKEMIA & LYMPHOMA (2015)
Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-cell Lymphomas A North American PTCL Study Group Project
Eric D. Hsi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma
Christine Damm-Welk et al.
BLOOD (2014)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology
Ayoma D. Attygalle et al.
HISTOPATHOLOGY (2014)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
Nancy L. Bartlett et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck
WeiGe Wang et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2014)
Anaplastic large cell lymphoma, ALK-negative
Andres J. M. Ferreri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Novel TRAF1-ALK Fusion Identified by Deep RNA Sequencing of Anaplastic Large Cell Lymphoma
Andrew L. Feldman et al.
GENES CHROMOSOMES & CANCER (2013)
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Sonali M. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors
Vivien Mak et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study
Pier Paolo Piccaluga et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P. Mosse et al.
LANCET ONCOLOGY (2013)
STAT3 mutations are frequent in CD30+T-cell lymphomas and T-cell large granular lymphocytic leukemia
R. S. Ohgami et al.
LEUKEMIA (2013)
t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
Stefan Ehrentraut et al.
PLOS ONE (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas
George Vasmatzis et al.
BLOOD (2012)
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
Luca Agnelli et al.
BLOOD (2012)
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
I. Oschlies et al.
HAEMATOLOGICA (2012)
Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Etude des Lymphomes de l'Adulte Trials
David Sibon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
Francesco d'Amore et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Werner Kempf et al.
BLOOD (2011)
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies
David A. Wada et al.
MODERN PATHOLOGY (2011)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz et al.
BLOOD (2010)
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms
Roberto Piva et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus
Andrew L. Feldman et al.
MODERN PATHOLOGY (2010)
Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation
Christine Damm-Welk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
Peter Reimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2009)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas
Itziar Salaverria et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: A study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Steven Le Gouill et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder
Anja C. Roden et al.
MODERN PATHOLOGY (2008)
Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma:: a prospective study from The Gel-Tamo Study Group
Jose Rodriguez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas
B Ballester et al.
ONCOGENE (2006)
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma -: The MD Anderson Cancer Center experience
MP Escalón et al.
CANCER (2005)
The emerging normal and disease-related roles of anaplastic lymphoma kinase
K Pulford et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas
HK Lee et al.
LEUKEMIA & LYMPHOMA (2002)
Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma
F Tort et al.
LABORATORY INVESTIGATION (2001)
Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology
ES Jaffe
MODERN PATHOLOGY (2001)
Share Paper
